Moreover, bromodomains have been shown to be part of the NRF2 transcriptional complex [53,54] and are associated with pancreatitis [83,85], and inhibitors are effective in reducing tumor progression in mouse models of pancreatic cancer [65]. This evidence concerns the gene NFE2L2 and pancreatic neoplasm.